Submitted:
23 June 2026
Posted:
24 June 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design and Setting
2.2. Participants and Case Definition
2.3. Outcome and Variables
2.4. Statistical Analysis

3. Results
3.1. Analytical Sample and Overall Disposition
3.2. Demographic, Clinical, Comorbidity and Operational Characteristics
| Characteristic | Total | Hospitalized/ transported |
Left at scene/ ambulatory |
p-value | Test |
|---|---|---|---|---|---|
| n (% of sample) | 9985 | 2676 (26.8%) | 7309 (73.2%) | ||
| Age, median (IQR), years | 68 (59-77) | 65 (56-73) | 70 (60-79) | <0.001 | Mann-Whitney U |
| Sex, n (%) | <0.001 | Pearson chi-square | |||
| Male | 4484 (44.9%) | 1502 (56.1%) | 2982 (40.8%) | ||
| Female | 5501 (55.1%) | 1174 (43.9%) | 4327 (59.2%) | ||
| Age group, n (%) | <0.001 | Pearson chi-square | |||
| <45 | 436 (4.4%) | 193 (7.2%) | 243 (3.3%) | ||
| 45–59 | 2205 (22.1%) | 719 (26.9%) | 1486 (20.3%) | ||
| 60–74 | 4231 (42.4%) | 1166 (43.6%) | 3065 (41.9%) | ||
| ≥75 | 3113 (31.2%) | 598 (22.3%) | 2515 (34.4%) | ||
| Urgency category, n (%) | <0.001 | Pearson chi-square | |||
| Category 1 | 186 (1.9%) | 65 (2.4%) | 121 (1.7%) | ||
| Category 2 | 8091 (81.0%) | 2106 (78.7%) | 5985 (81.9%) | ||
| Category 3 | 1444 (14.5%) | 452 (16.9%) | 992 (13.6%) | ||
| Category 4 | 264 (2.6%) | 53 (2.0%) | 211 (2.9%) | ||
| Main diagnosis, n (%) | <0.001 | Pearson chi-square | |||
| Acute/unstable IHD | 423 (4.2%) | 302 (11.3%) | 121 (1.7%) | ||
| Chronic IHD (I25) | 9562 (95.8%) | 2374 (88.7%) | 7188 (98.3%) | ||
| Crew type, n (%) | 0.593 | Pearson chi-square | |||
| Specialized | 1074 (10.8%) | 280 (10.5%) | 794 (10.9%) | ||
| General/line | 8911 (89.2%) | 2396 (89.5%) | 6515 (89.1%) | ||
| Comorbidities/complications, n (%) | |||||
| Diabetes mellitus (E10-E14) | 83 (0.8%) | 23 (0.9%) | 60 (0.8%) | 0.949 | Pearson chi-square |
| COPD/obstructive disease (J40-J47) | 109 (1.1%) | 29 (1.1%) | 80 (1.1%) | 1.000 | Pearson chi-square |
| Arterial hypertension (I10-I15) | 1118 (11.2%) | 279 (10.4%) | 839 (11.5%) | 0.149 | Pearson chi-square |
| Heart failure (I50) | 3071 (30.8%) | 1011 (37.8%) | 2060 (28.2%) | <0.001 | Pearson chi-square |
| Atrial fibrillation (I48) | 2043 (20.5%) | 555 (20.7%) | 1488 (20.4%) | 0.696 | Pearson chi-square |
| Other arrhythmias (I47, I49) | 2204 (22.1%) | 669 (25.0%) | 1535 (21.0%) | <0.001 | Pearson chi-square |
| Cardiogenic shock (R57.0) | 99 (1.0%) | 88 (3.3%) | 11 (0.2%) | <0.001 | Pearson chi-square |
| Pneumonia (J12-J18) | 106 (1.1%) | 32 (1.2%) | 74 (1.0%) | 0.495 | Pearson chi-square |
| Time intervals, median (IQR), min | |||||
| Call to crew arrival | 14 (11-16) | 14 (11-16) | 14 (11-16) | 0.589 | Mann-Whitney U |
| Arrival to hospital delivery | 62 (52-74) | 62 (52-74) | 63 (47-78) | 0.694 | Mann-Whitney U |
3.3. Multivariable Predictors of Emergency Hospitalization/Transport

| Predictor | aOR | 95% CI | p-value |
|---|---|---|---|
| Cardiogenic shock | 15.06 | 7.79-29.13 | <0.001 |
| Acute/unstable IHD (vs. chronic I25) | 8.52 | 6.74-10.76 | <0.001 |
| Heart failure | 2.46 | 2.17-2.79 | <0.001 |
| Age <45 years (vs. 60-74 years) | 1.88 | 1.51-2.33 | <0.001 |
| Other arrhythmias | 1.84 | 1.62-2.10 | <0.001 |
| Male sex (vs. female) | 1.65 | 1.49-1.82 | <0.001 |
| Atrial fibrillation | 1.60 | 1.40-1.82 | <0.001 |
| Pneumonia | 1.32 | 0.84-2.08 | 0.228 |
| COPD | 1.24 | 0.79-1.94 | 0.352 |
| Age 45-59 years (vs. 60-74 years) | 1.18 | 1.05-1.33 | 0.006 |
| Arterial hypertension | 1.18 | 0.98-1.41 | 0.080 |
| Diabetes mellitus | 1.12 | 0.65-1.92 | 0.681 |
| Complication present (DS3) | 1.05 | 0.93-1.19 | 0.407 |
| Response time (per +10 min) | 1.05 | 1.01-1.09 | 0.012 |
| High urgency (category 1-2) | 0.84 | 0.73-0.96 | 0.012 |
| Specialized crew | 0.84 | 0.71-0.98 | 0.029 |
| Age ≥75 years (vs. 60-74 years) | 0.61 | 0.54-0.69 | <0.001 |
3.4. Model Performance and Internal Validation
3.5. Graphical Summary of Clinical Disposition and Comorbidity Burden
3.6. Age Distribution, Annual Dynamics and Response-Time Pattern
4. Discussion
4.1. Acuity, Comorbidity and the Wider Evidence
4.2. Response Time, Demography and the Crew-Side Decision
4.3. Methodological Context and Implications
4.4. Strengths and Limitations
4.5. Future Directions
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| ACS | Acute coronary syndrome |
| AMI | Acute myocardial infarction |
| aOR | Adjusted odds ratio |
| AUC | Area under the curve |
| CI | Confidence interval |
| COPD | Chronic obstructive pulmonary disease |
| DS2 | Secondary diagnosis coding field |
| DS3 | Documented complication coding field |
| ED | Emergency department |
| EMS | Emergency medical service |
| ICD-10 | International Classification of Diseases, 10th Revision |
| IHD | Ischemic heart disease |
| IQR | Interquartile range |
| NSTEMI | Non-ST-elevation myocardial infarction |
| OR | Odds ratio |
| PCI | Percutaneous coronary intervention |
| ROC | Receiver-operating-characteristic |
| STEMI | ST-elevation myocardial infarction |
| STROBE | Strengthening the Reporting of Observational Studies in Epidemiology |
References
- GBD 2023 Cardiovascular Diseases Collaborators. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990–2023. J. Am. Coll. Cardiol. 2025, 86, 2167–2243. [CrossRef]
- Mensah, G.A.; Fuster, V.; Murray, C.J.L.; Roth, G.A.; the Global Burden of Cardiovascular Diseases and Risks Collaborators. Global Burden of Cardiovascular Diseases and Risks, 1990–2022. J. Am. Coll. Cardiol. 2023, 82, 2350–2473.
- Khan, M.A.; Hashim, M.J.; Mustafa, H.; Baniyas, M.Y.; Al Suwaidi, S.K.B.M.; AlKatheeri, R.; et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus 2020, 12, e9349. [CrossRef]
- Vaduganathan, M.; Mensah, G.A.; Turco, J.V.; Fuster, V.; Roth, G.A. The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health. J. Am. Coll. Cardiol. 2022, 80, 2361–2371. [CrossRef]
- Timmis, A.; Vardas, P.; Townsend, N.; Torbica, A.; Katus, H.; De Smedt, D.; et al. European Society of Cardiology: Cardiovascular Disease Statistics 2021. Eur. Heart J. 2022, 43, 716–799. [CrossRef]
- Supiyev, A.; Nurgozhin, T.; Zhumadilov, Z.; Peasey, A.; Hubacek, J.A.; Bobak, M. Prevalence, Awareness, Treatment and Control of Cardiovascular Risk Factors in Older Adults in Kazakhstan. Sci. Rep. 2017, 7, 44743.
- Khaled, M.F.I.; Adhikary, D.K.; Islam, M.M.; Alam, M.M.; Rahman, M.W.; Chowdhury, M.T.; et al. Factors Responsible for Prehospital Delay in Patients with Acute Coronary Syndrome in Bangladesh. Medicina 2022, 58, 1206. [CrossRef]
- Ohtaroglu Tokdil, K.; Tokdil, H.; Durmaz, E.; Karadag, B.; Kilickiran Avci, B.; Ikitimur, B.; et al. The Determinants of Delays and Their Impact on Clinical End Points in Acute ST-Segment Elevation Myocardial Infarction: A Single-Center Experience. Medicina 2025, 61, 447. [CrossRef]
- Chang, J.; Deng, Q.; Hu, P.; Yang, Z.; Guo, M.; Lu, F.; et al. Driving Time to the Nearest Percutaneous Coronary Intervention-Capable Hospital and the Risk of Case Fatality in Patients with Acute Myocardial Infarction in Beijing. Int. J. Environ. Res. Public Health 2023, 20, 3166. [CrossRef]
- Al-Zaiti, S.; Besomi, L.; Bouzid, Z.; Faramand, Z.; Frisch, S.; Martin-Gill, C.; Gregg, R.; Saba, S.; Callaway, C.; Sejdić, E. Machine Learning-Based Prediction of Acute Coronary Syndrome Using Only the Pre-Hospital 12-Lead Electrocardiogram. Nat. Commun. 2020, 11, 3966. [CrossRef]
- Wibring, K.; Lingman, M.; Herlitz, J.; Ashfaq, A.; Bång, A. Development of a Prehospital Prediction Model for Risk Stratification of Patients with Chest Pain. Am. J. Emerg. Med. 2022, 51, 26–31. [CrossRef]
- Spangler, D.; Blomberg, H.; Smekal, D. The Potential of New Prediction Models for Emergency Medical Dispatch Prioritisation of Patients with Chest Pain. Scand. J. Trauma Resusc. Emerg. Med. 2022, 30, 34. [CrossRef]
- Pirneskoski, J.; Tamminen, J.; Kallonen, A.; Nurmi, J.; Kuisma, M.; Olkkola, K.T.; et al. Random Forest Machine Learning Method Outperforms Prehospital National Early Warning Score for Predicting One-Day Mortality. Resusc. Plus 2020, 4, 100046. [CrossRef]
- Paulin, J.; Reunamo, A.; Kurola, J.; Moen, H.; Salanterä, S.; Riihimäki, H.; Vesanen, T.; Koivisto, M.; Iirola, T. Using Machine Learning to Predict Subsequent Events after EMS Non-Conveyance Decisions. BMC Med. Inform. Decis. Mak. 2022, 22, 166. [CrossRef]
- Ebben, R.H.A.; Vloet, L.C.M.; Speijers, R.F.; Tönjes, N.W.; Loef, J.; Pelgrim, T.; et al. A Patient-Safety and Professional Perspective on Non-Conveyance in Ambulance Care: A Systematic Review. Scand. J. Trauma Resusc. Emerg. Med. 2017, 25, 71. [CrossRef]
- Granlund, L.; Brännström, I.; Lindström, V. Factors Influencing Non-Conveyance Care Encounters in the Ambulance Service: Registered Nurses' Experiences—A Qualitative Study. BMC Nurs. 2024, 23, 271. [CrossRef]
- Ruiz-Ramos, J.; Vela, E.; Monterde, D.; Blázquez-Andión, M.; Puig-Campmany, M.; Piera-Jiménez, J.; et al. Healthcare Risk Stratification Model for Emergency Departments Based on Drugs, Income and Comorbidities: The DICER-Score. BMC Emerg. Med. 2024, 24, 23. [CrossRef]
- Blayney, M.C.; Reed, M.J.; Masterson, J.A.; Anand, A.; Bouamrane, M.-M.; Fleuriot, J.; Luz, S.; Lyall, M.J.; Mercer, S.; Mills, N.L.; et al. Multimorbidity and Adverse Outcomes Following Emergency Department Attendance: Population-Based Cohort Study. BMJ Med. 2024, 3, e000731. [CrossRef]
- Chae, S.; Davoudi, A.; Song, J.; Evans, L.; Hobensack, M.; Bowles, K.H.; et al. Predicting Emergency Department Visits and Hospitalizations for Patients with Heart Failure in Home Healthcare Using a Time Series Risk Model. J. Am. Med. Inform. Assoc. 2023, 30, 1622–1633. [CrossRef]
- Fine, N.M.; Kalmady, S.V.; Sun, W.; Greiner, R.; Howlett, J.G.; White, J.A.; et al. Machine Learning for Risk Prediction after Heart Failure Emergency Department Visit or Hospital Admission Using Administrative Health Data. PLOS Digit. Health 2024, 3, e0000636. [CrossRef]
- McDonagh, T.A.; Metra, M.; Adamo, M.; Gardner, R.S.; Baumbach, A.; Böhm, M.; et al. 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Eur. Heart J. 2021, 42, 3599–3726. [CrossRef]
- Bozkurt, B.; Ahmad, T.; Alexander, K.; Baker, W.L.; Bosak, K.; Breathett, K.; et al. HF Stats 2024: Heart Failure Epidemiology and Outcomes Statistics—A Report of the Heart Failure Society of America. J. Card. Fail. 2025, 31, 66–116. [CrossRef]
- Srivatsa, S.; Pazooki, P.; Lau, B.K.; Waller, A.; Brown, A.B.; McDonald, K.; Gehi, A.; Rosamond, W. Trends and Predictors of Emergency Department Outcomes in Atrial Fibrillation: A Statewide Analysis from North Carolina—2016 to 2023. J. Am. Coll. Emerg. Physicians Open 2025, 7, 100279. [CrossRef]
- Manemann, S.M.; Alonso, A.; Noseworthy, P.A.; Siontis, K.C.; Gersh, B.J.; Roger, V.L.; Ryu, E.; Killian, J.M.; Weston, S.A.; Vaughan, L.E.; et al. Multimorbidity in Atrial Fibrillation: Impact on Outcomes. J. Am. Heart Assoc. 2026, 15, e040612. [CrossRef]
- Jentzer, J.C.; Pöss, J.; Schaubroeck, H.; Morrow, D.A.; Hollenberg, S.M.; Mebazaa, A. Advances in the Management of Cardiogenic Shock. Crit. Care Med. 2023, 51, 1222–1233. [CrossRef]
- Kapur, N.K.; Kanwar, M.; Sinha, S.S.; Thayer, K.L.; Garan, A.R.; Hernandez-Montfort, J.; et al. Criteria for Defining Stages of Cardiogenic Shock Severity. J. Am. Coll. Cardiol. 2022, 80, 185–198. [CrossRef]
- Botti, G.; Pieri, M.; Cappannoli, L.; Munafò, A.R.; Gramegna, M.; Camporotondo, R.; et al. Patterns of Disease Progression and Outcomes of Inferior ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: The INSTINCT Registry. J. Clin. Med. 2025, 14, 2231. [CrossRef]
- Zeymer, U.; Bueno, H.; Granger, C.B.; Hochman, J.; Huber, K.; Lettino, M.; et al. Acute Cardiovascular Care Association Position Statement for the Diagnosis and Treatment of Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock. Eur. Heart J. Acute Cardiovasc. Care 2020, 9, 183–197. [CrossRef]
- Lawesson, S.S.; Isaksson, R.M.; Thylén, I.; Ericsson, M.; Ängerud, K.; Swahn, E. Gender Differences in Symptom Presentation of ST-Elevation Myocardial Infarction—An Observational Multicenter Survey Study. Int. J. Cardiol. 2018, 264, 7–11. [CrossRef]
- Bugiardini, R.; Cenko, E. Sex Differences in Myocardial Infarction Deaths. Lancet 2020, 396, 72–73. [CrossRef]
- Mamas, M.A.; Kwok, C.S.; Kontopantelis, E.; Fryer, A.A.; Wu, J.; Myint, P.K.; et al. Invasive Management and In-Hospital Outcomes of Myocardial Infarction Patients in Rural versus Urban Hospitals in the United States. Cardiovasc. Revasc. Med. 2023, 46, 3–9. [CrossRef]
- Chayakova, A.; Tsigengagel, O. Urban Environmental Determinants and Spatiotemporal Patterns of Emergency Medical Service Response to Traumatic Injuries: A Five-Year Population-Based Study. Int. J. Environ. Res. Public Health 2026, 23, 434. [CrossRef]
- Rasmussen, M.B.; Frost, L.; Stengaard, C.; Brorholt-Petersen, J.U.; Dodt, K.K.; Søndergaard, H.M.; et al. Diagnostic Performance and System Delay Using Telemedicine for Prehospital Diagnosis in Triaging and Treatment of STEMI. Heart 2014, 100, 711–715. [CrossRef]
- Byrne, R.A.; Rossello, X.; Coughlan, J.J.; Barbato, E.; Berry, C.; Chieffo, A.; et al. 2023 ESC Guidelines for the Management of Acute Coronary Syndromes. Eur. Heart J. 2023, 44, 3720–3826. [CrossRef]
- Visseren, F.L.J.; Mach, F.; Smulders, Y.M.; Carballo, D.; Koskinas, K.C.; Bäck, M.; et al. 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Eur. Heart J. 2021, 42, 3227–3337.
- Wilson, M.H.; Habig, K.; Wright, C.; Hughes, A.; Davies, G.; Imray, C.H.E. Pre-Hospital Emergency Medicine. Lancet 2015, 386, 2526–2534. [CrossRef]
- von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gøtzsche, P.C.; Vandenbroucke, J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement. Lancet 2007, 370, 1453–1457. [CrossRef]




Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).